Evidence map›Paper›PMID 22828636›Full record

ArticleNeuropharmacology2012

Mixed antagonistic effects of the ginkgolides at recombinant human ρ1 GABAC receptors.

Shelley H Huang, Trevor M Lewis, Sarah C R Lummis, Andrew J Thompson, Mary Chebib, Graham A R Johnston, Rujee K Duke

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Neuroregulatory role of ginkgolides.Molecular biology reports · 2021
    Review
  2. VERIFICATION OF AUTHENTICITY OFActa clinica Croatica · 2019
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shelley H HuangDiscipline of Pharmacology, School of Medical Sciences, Faculty of Medicine, University of Sydney, Australia.
Trevor M Lewis
Sarah C R Lummis
Andrew J Thompson
Mary Chebib
Graham A R Johnston
Rujee K Duke
University of Cambridge · GBUniversity of Sydney · AUUNSW Sydney · AU

Funding

Wellcome Trust
6 · The paper itself

Abstract

The diterpene lactones of Ginkgo biloba, ginkgolides A, B and C are antagonists at a range of Cys-loop receptors. This study examined the effects of the ginkgolides at recombinant human ρ(1) GABA(C) receptors expressed in Xenopus oocytes using two-electrode voltage clamp. The ginkgolides were moderately potent antagonists with IC(50)s in the μM range. At 10 μM, 30 μM and 100 μM, the ginkgolides caused rightward shifts of GABA dose-response curves and reduced maximal GABA responses, characteristic of noncompetitive antagonists, while the potencies showed a clear dependence on GABA concentration, indicating apparent competitive antagonism. This suggests that the ginkgolides exert a mixed-type antagonism at the ρ(1) GABA(C) receptors. The ginkgolides did not exhibit any obvious use-dependent inhibition. Fitting of the data to a number of kinetic schemes suggests an allosteric inhibition as a possible mechanism of action of the ginkgolides which accounts for their inhibition of the responses without channel block or use-dependent inhibition. Kinetic modelling predicts that the ginkgolides exhibit saturation of antagonism at high concentrations of GABA, but this was only partially observed for ginkgolide B. It also suggests that there may be different binding sites in the closed and open states of the receptor, with a higher affinity for the receptor in the closed state.

Indexed as

AlgorithmsAnimalsDose-Response Relationship, DrugGABA AntagonistsGinkgolidesHumansKineticsModels, MolecularOocytesPatch-Clamp TechniquesReceptors, GABARecombinant ProteinsStructure-Activity RelationshipXenopus laevisGABA AntagonistsGinkgolidesReceptors, GABARecombinant Proteinsrho1 GABA(C) receptor, human

Identifiers

PMID22828636
PMCPMC3465557
OpenAlexW1976349563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.